Search

everythinglearnresearchcommunity

for

Search:↓

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Women with PCOS have altered brain structure and reduced cognitive performance.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Physical activity, height, and smoking affect prostate cancer risk.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Melanocytes are diverse cells important for pigmentation and skin health, influenced by genetics and environment.

3D-oxy exosomes may significantly boost hair growth, offering new treatment options for hair loss.

No single biomarker is reliable enough for diagnosing and assessing SLE.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Oxidative stress contributes to hair graying and loss as we age.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.